LMF
ENZN

LMR Master Fund’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

LMR Master Fund’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$20K Buy
+17,368
New +$26.7K ﹤0.01% 344

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

LMR Master Fund's ENZN Position: Q4 2013 in Review

LMR Master Fund opened a new position in ENZON PHARMACEUTICALS INC (ENZN) in Q4 2013: 17,368 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #344 among its holdings.

79 funds tracked by Wall St. Rank hold ENZN as of Q4 2013.

  • LMR Master Fund held 17,368 shares of ENZON PHARMACEUTICALS INC worth $20K as of Q4 2013.
  • ENZON PHARMACEUTICALS INC was a new LMR Master Fund position in Q4 2013.
  • ENZON PHARMACEUTICALS INC made up ﹤0.01% of LMR Master Fund's portfolio in Q4 2013, its #344 holding.
  • 79 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.